Charles Deignan

(Mr. Charles Deignan)

Currently holds a position at Clearside Biomedical Inc

Positions

Position Company Period
Chief Financial Officer Clearside Biomedical Inc Jan. 1, 2012 -
Charles Deignan's trades of Clearside Biomedical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-19 2024-01-19
S Sale
12,900 -3.2%
1.28
USD 16,512 		12,900 -3.2% 1.28 USD 16,512
2023-01-20 2023-01-19
PS Planned sale
14,030 -3.7%
1.50
USD 21,045 		14,030 -3.7% 1.50 USD 21,045
2022-01-20 2022-01-19
PS Planned sale
8,833 -2.5%
2.09
USD 18,461 		8,833 -2.5% 2.09 USD 18,461
2021-06-23 2021-06-21
PS Planned sale
2,938 -0.9%
4.37
USD 12,839 		2,938 -0.9% 4.37 USD 12,839
2020-06-03 2020-06-01
PS Planned sale
14,992 -6.4%
1.88
USD 28,185 		14,992 -6.4% 1.88 USD 28,185
2019-11-13 2019-11-12
B Purchase
7,500 +3.8%
1.14
USD 8,550 		7,500 +3.8% 1.14 USD 8,550
2019-03-18 2019-03-15
B Purchase
10,000 +15.1%
1.36
USD 13,600 		10,000 +15.1% 1.36 USD 13,600
2018-03-26 2018-03-23
B Purchase
500 +0.8%
11.79
USD 5,895 		500 +0.8% 11.79 USD 5,895
2017-08-14 2017-08-14
B Purchase
1,000 +1.6%
7.07
USD 7,065 		1,000 +1.6% 7.07 USD 7,065
2016-06-07 2016-06-07
S Sale
2 -0.0%
7.00
USD 14 		2 -0.0% 7.00 USD 14
// ... existing code ... // ... rest of the file ...